Alexion Pharmaceuticals, Inc.
MONOVALENT ANTI-PROPERDIN ANTIBODIES AND ANTIBODY FRAGMENTS
Last updated:
Abstract:
Described herein are isolated monovalent antibodies or antibody fragments thereof that bind human properdin. Such antibodies are useful in methods of treatment for diseases mediated by alternative complement pathway dysregulation.
Status:
Application
Type:
Utility
Filling date:
9 Nov 2021
Issue date:
26 May 2022